Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
about
Antifungal application of nonantifungal drugsIn vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infectionsThe effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patientsThe epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida BiofilmsAntibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infectionEffect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia.Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coliDerivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemia.The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients.Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolonesVariation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to Echinocandins in Candida glabrata.Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility.Thriving within the host: Candida spp. interactions with phagocytic cells.The Candida pathogenic species complex.Antifungal drug resistance among Candida species: mechanisms and clinical impact.Azole Resistance in Candida glabrata.Risk factors for fluconazole-resistant candidemia.Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China.Synthesis and Biological Evaluation of Novel Alkyl-Imidazolyl Carbinols and their Esters: Potent Antimycotics.Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains.EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.Fluconazole-resistant Candida: collateral damage associated with prior antibacterial exposure?Problems related to antifungal prescription: a qualitative study of the views of intensivists.Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.Jjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Candida glabrata.
P2860
Q30433553-00591808-8E92-4E0A-BD14-157974C8DA30Q33851255-767FDD86-053C-4107-9603-AA84F541BFA4Q33887429-3091C54D-E17D-48B5-A407-517F7F489E5DQ34529026-045BA70D-206A-481F-AB0B-2D29FDAF5940Q34586566-7B70CAE5-F9DF-4EDB-A96D-EC74E02A4524Q35558411-E7932474-7CA0-47A1-A3AE-1AB3EE837FBCQ35886365-DEF08F05-7F8A-4E57-87DE-BB2373E8CDC8Q35941512-4CBA89AB-82C5-4FB4-9812-AC0E5513562CQ36276932-29FEE928-FFC5-4C9A-8424-A78312BB62DDQ36330973-7D7DA0FB-8C36-4323-8D66-BDDA26413F7FQ36456630-83469AAC-DF62-4EB7-A4F5-CB4EC1C5E1F6Q36457109-F093217E-1856-4FED-9D9F-3ED4E0804183Q37012419-FEC12BAF-E52C-48A0-8A9A-88D0BB6D62D9Q37049823-4BD98C6E-46C3-4BA9-B152-593D6547BE55Q37374850-B51A538C-996E-45B3-9E30-19E43B6A1EC4Q37580801-0DC89389-C93B-4660-A267-6BB92836C2CCQ37643499-98A9D170-4CCD-4445-9D35-97A897BE659CQ37691788-506E971B-BFF4-4599-BD96-41FFB5599798Q38077110-4C5125A1-05B2-4CE4-85E6-33B7830CF8FAQ38245727-1190736D-BC9A-4C41-BDE4-E115C3B9EDADQ38511946-7C916EEC-AA6D-46AC-A498-27399F463678Q38985818-A70ED180-FBAD-40E6-8A8E-C5CCE1313995Q39934814-7B8F1F21-DCD3-4567-9FEC-DE2E6ED92AB2Q40169961-338955A8-F16A-44DC-8AA3-2BBAB58A5A20Q41085151-EE4BFDB4-D408-475D-ABC7-5905067BD439Q42042096-CEE398DB-322A-474F-A6EE-3D15327F163FQ43108559-AA7CB6B8-C77C-4019-882A-122F8180B0C5Q44013179-3077920B-2DF2-4E4F-A3C5-C7B32BCACC02Q44919501-F548081E-8140-41EF-9880-13E81E1132DFQ45895673-812C6CCB-3689-4064-8D9D-A70DFBA54FE7Q47147760-ED190AE7-986D-4147-A44B-9EDDDB8E833FQ51149332-8F7B4547-1558-4221-98D8-85BC211454A9
P2860
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
@ast
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
@en
type
label
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
@ast
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
@en
prefLabel
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
@ast
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
@en
P2093
P2860
P1476
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections
@en
P2093
Ebbing Lautenbach
Irving Nachamkin
Knashawn H Morales
Marie Synnestvedt
Mark G Weiner
Neil O Fishman
Theoklis E Zaoutis
P2860
P304
P356
10.1001/ARCHINTE.169.4.379
P407
P577
2009-02-01T00:00:00Z